Research / NVT / Fundamental state Inspectable configuration
State dimensions Filing 0001720635-24-000012 General Corporate
Debt relative to revenue 25th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.debt_to_revenue
54.56% · OPTIONAL · VALID
Capex intensity 90th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.capex_revenue_ratio
2.18% · OPTIONAL · VALID
Operating cash generation 65th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
16.18% · OPTIONAL · VALID
Share-count growth 89th Own-history percentile · N=19
Evidence method Yoy · gp.fundamentals.shares_outstanding
-0.17% · CORE · VALID
Revenue growth 58th Own-history percentile · N=19
Evidence method Yoy · gp.fundamentals.revenue
12.19% · CORE · VALID
Inventory pressure 25th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
13.52% · OPTIONAL · VALID
Gross margin 90th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.gross_margin
41.12% · CORE · VALID
Operating margin 90th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.operating_margin
18.00% · CORE · VALID
R&D intensity 75th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
2.19% · OPTIONAL · VALID
SBC intensity 50th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
0.72% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 34 states Self-history eligible
Sep 30, 2021 10/10 normalized Level 3 Dec 31, 2021 10/10 normalized Level 3 Mar 31, 2022 10/10 normalized Level 3 Jun 30, 2022 7/7 normalized Level 3 Sep 30, 2022 7/7 normalized Level 3 Dec 31, 2022 10/10 normalized Level 3 Mar 31, 2023 10/10 normalized Level 3 Jun 30, 2023 10/10 normalized Level 3 Sep 30, 2023 10/10 normalized Level 3 Dec 31, 2023 10/10 normalized Level 3 Mar 31, 2024 10/10 normalized Level 3 Jun 30, 2024 10/10 normalized Level 3 Sep 30, 2024 10/10 normalized Level 3 Dec 31, 2024 10/10 normalized Level 3 Mar 31, 2025 10/10 normalized Level 3 Jun 30, 2025 10/10 normalized Level 3 Sep 30, 2025 10/10 normalized Level 3 Dec 31, 2025 10/10 normalized Level 3 Mar 31, 2026 10/10 normalized Level 3 Jun 30, 2026 10/10 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Decreased
Previous 213.26%
Current 54.56%
Delta -158.70% Capex Intensity Increased
Previous 1.93%
Current 2.18%
Delta 0.24% Cash Generation Decreased
Previous 16.88%
Current 16.18%
Delta -0.70% Dilution Increased
Previous -0.41%
Current -0.17%
Delta 0.24% Growth Decreased
Previous 15.24%
Current 12.19%
Delta -3.05% Inventory Pressure Decreased
Previous 54.13%
Current 13.52%
Delta -40.61% Margin Decreased
Previous 41.13%
Current 41.12%
Delta -0.00% Profitability Decreased
Previous 18.19%
Current 18.00%
Delta -0.19% R And D Intensity Increased
Previous 2.13%
Current 2.19%
Delta 0.06% Sbc Intensity Increased
Previous 0.71%
Current 0.72%
Delta 0.01% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.